PTC Therapeutics
PTCT
#2695
Rank
A$9.28 B
Marketcap
A$111.96
Share price
7.18%
Change (1 day)
43.28%
Change (1 year)

PTC Therapeutics (PTCT) - Net assets

Net assets on the balance sheet as of March 2026 : -A$0.26 Billion

According to PTC Therapeutics 's latest financial reports the company has -A$0.26 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

PTC Therapeutics - Net assets on balance sheet (from 2012 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-A$0.31 Billion-82.64%
2024-12-31$-A$1.77 Billion46.94%
2023-12-31$-A$1.21 Billion135.56%
2022-12-31$-A$0.52 Billion-25814.25%
2021-12-31$A$1.98 M-99.68%
2020-12-31$A$0.62 B-26.16%
2019-12-31$A$0.84 B70.51%
2018-12-31$A$0.49 B148.46%
2017-12-31$A$0.20 B20.79%
2016-12-31$A$0.16 B-46.52%
2015-12-31$A$0.31 B-14.93%
2014-12-31$A$0.36 B138.24%
2013-12-31$A$0.15 B-928.77%
2012-12-31$-A$18.48 Million-92.06%
2011-12-31$-A$0.24 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novartis
NVS
A$55.49 B-21,670.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
A$27.60 B-10,828.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
A$0.90 B-452.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$2.14 B-934.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
A$0.33 B-229.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
A$2.40 B-1,035.69%๐Ÿ‡บ๐Ÿ‡ธ USA